· Published by Health Canada · Official notice
| Brand | Lot | Product Name | Market Authorization | Dosage Form | Strength |
|---|---|---|---|---|---|
| PancreaKare Powder | 23PKP05111, 23PKP05161, 23PKP05191, 23PKP05231 | PancreaKare Powder | No Market Authorization | Powder | N/A |
Product sold without market authorization (DIN) Canada. Product contains undeclared pancreatin that is listed on the Prescription Drug List (provides more than 20 000 USP units of lipase activity/dose).